August 26th, 2020
Anthony Fauci, MD, Director
National Institute of Allergy and Infectious Disease
RE: Phase III Moderna mRNA-1273 Vaccine
Dear Dr. Fauci,
We urge you to require Moderna to inform clinical trial participants of the unique risks associated with polyethylene glycol (PEG), an ingredient in the NIAID funded Moderna mRNA-1273 vaccine. As you know, approximately 72% of Americans may have antibodies to PEG with 8% of those individuals having highly elevated levels of antibodies, >500ng/ml.